{"meta":{"query_hash":"c2162fb467e9","filters":{"venue":"Blood Cancer Discovery"},"cohort_total":47,"direct_labels_cover":0,"predictions_cover":47,"exported":47,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c2162fb467e9","api":"https://metacan.xera.ac/api/v1/cohort?venue=Blood+Cancer+Discovery"},"results":[{"id":"W2999773798","doi":"10.1158/0008-5472.bcd-19-0041","title":"Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; KWF Kankerbestrijding; China Scholarship Council","keywords":"Lymphoblastic Leukemia; Somatic evolution in cancer; Cancer research; Medicine; Biology; Leukemia; Genetics; Oncology; Gene","score_opus":0.010678445614332796,"score_gpt":0.25802104514468605,"score_spread":0.24734259953035326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999773798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962891,0.0012290144,0.0008595472,0.00079554226,0.000081570644,0.00028803112,0.0002781449,0.000024080156,0.00015502426],"genre_scores_gemma":[0.99821967,0.000534491,0.00012689274,0.0003411985,0.00046224834,0.000058426016,0.00006895378,0.000028594048,0.00015951978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983335,0.00004210714,0.00037327924,0.00038048273,0.00056834705,0.0003022907],"domain_scores_gemma":[0.99930394,0.00017044423,0.0001182743,0.0001379035,0.00008156353,0.00018790281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009249105,0.00017217876,0.00035392283,0.00017631598,0.000030258994,0.000020722207,0.00010253151,0.00011175179,0.00010289918],"category_scores_gemma":[0.00012660652,0.00015472108,0.000071973125,0.0004369278,0.000060656315,0.00018132337,0.00010100753,0.00020246996,0.000007918352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013896137,0.00014966103,0.9896543,0.0006948644,0.00023036086,0.00031474128,0.0004651987,0.00077317515,0.0051663206,0.0002908841,0.00064002763,0.0002308579],"study_design_scores_gemma":[0.015617867,0.00063364406,0.9708479,0.0002025428,0.00076212134,0.00015295498,0.00022508629,0.009433391,0.0017629866,0.00009853164,0.000026359176,0.00023660324],"about_ca_topic_score_codex":0.0003602316,"about_ca_topic_score_gemma":0.000047783902,"teacher_disagreement_score":0.018806381,"about_ca_system_score_codex":0.0005065639,"about_ca_system_score_gemma":0.0024896122,"threshold_uncertainty_score":0.6309343},"labels":[],"label_agreement":null},{"id":"W3009636168","doi":"10.1158/0008-5472.bcd-19-0039","title":"Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; National Institutes of Health; Cancer Research Society; National Natural Science Foundation of China; American Cyronics Society; U.S. Department of Defense","keywords":"Progenitor cell; Cancer research; Protein phosphatase 2; Biology; Stem cell; Immune system; Immunology; Leukemia; Apoptosis; Cell biology; Phosphatase; Phosphorylation","score_opus":0.015850457976143317,"score_gpt":0.20717159285903383,"score_spread":0.19132113488289051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009636168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957305,0.0026097863,0.000015745374,0.00009671699,0.0006117243,0.00028803144,0.0001138902,0.000020805868,0.00051275373],"genre_scores_gemma":[0.9978356,0.0005793255,0.000005408554,0.00028176422,0.000018110799,0.000029955592,0.00004599723,0.000016308764,0.0011875627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988434,0.00019475707,0.0003456216,0.0003433558,0.000052924996,0.00021995629],"domain_scores_gemma":[0.9993977,0.00012898253,0.00023078539,0.00014871992,0.00006445723,0.000029386645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008474252,0.00020123462,0.0003082204,0.00007961464,0.00017855412,0.0000320108,0.00008511357,0.00010280309,0.00006294644],"category_scores_gemma":[0.000017544819,0.00018544894,0.00006625958,0.00015435708,0.00010932752,0.0003797891,0.00008528562,0.00036840266,0.000010342705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015286491,0.0003322152,0.019493496,0.0001536856,0.0001238696,0.0000013628088,0.0031055342,0.000057940237,0.97359073,0.000010444668,0.0007017238,0.0009003195],"study_design_scores_gemma":[0.0038699028,0.0007996827,0.020065622,0.00021365577,0.000094606105,0.0000029596208,0.00771739,0.000034344223,0.96565473,0.0000021676174,0.0012910955,0.00025384498],"about_ca_topic_score_codex":0.0006271534,"about_ca_topic_score_gemma":0.0000978453,"teacher_disagreement_score":0.007936031,"about_ca_system_score_codex":0.0000678327,"about_ca_system_score_gemma":0.000091666865,"threshold_uncertainty_score":0.7562388},"labels":[],"label_agreement":null},{"id":"W3086857979","doi":"10.1158/2643-3230.bcd-20-0076","title":"PRPS-ST: A Protocol-Agnostic Self-training Method for Gene Expression–Based Classification of Blood Cancers","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Terry Fox Research Institute","keywords":"Computer science; Gene expression; Gene; Porting; Training set; Artificial intelligence; Machine learning; Computational biology; Data mining; Biology; Genetics","score_opus":0.039539593716895756,"score_gpt":0.3265509782736628,"score_spread":0.28701138455676706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086857979","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27461576,0.0028869847,0.63452655,0.00527273,0.0008525744,0.0778542,0.0023495085,0.00028623032,0.0013554961],"genre_scores_gemma":[0.8570201,0.00009157511,0.03774498,0.0011920403,0.0008259545,0.10253393,0.00032041507,0.00008541465,0.00018562117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812156,0.000110652254,0.00045834895,0.00073399907,0.00026526648,0.00031020126],"domain_scores_gemma":[0.99872243,0.000046790254,0.00044199143,0.00044859864,0.00017635887,0.0001638287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018277881,0.0002589566,0.00029562952,0.000055346194,0.00010610913,0.000044016277,0.00032933042,0.00018737015,0.00003223446],"category_scores_gemma":[0.00014577444,0.00024166079,0.00019571623,0.00022282152,0.000051793017,0.000022492703,0.000066953246,0.000100878904,7.0853906e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048406757,0.0001789704,0.0009247735,0.00035976214,0.00015428239,6.513816e-7,0.00022603165,0.001422814,0.99120224,0.000060642928,0.0033585299,0.0016272186],"study_design_scores_gemma":[0.0033391737,0.0005240223,0.00069016416,0.000125349,0.00028631202,0.0000016819923,0.00019580065,0.0016237166,0.95977753,0.000035754394,0.033096094,0.0003044222],"about_ca_topic_score_codex":0.000030586263,"about_ca_topic_score_gemma":0.000023186602,"teacher_disagreement_score":0.59678155,"about_ca_system_score_codex":0.000032316726,"about_ca_system_score_gemma":0.0011725011,"threshold_uncertainty_score":0.9854641},"labels":[],"label_agreement":null},{"id":"W3106693055","doi":"10.1158/2643-3249.lymphoma20-ia08","title":"Abstract IA08: The role of gene expression in the classification of aggressive B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Gene expression profiling; B cell; Immunophenotyping; Computational biology; Follicular lymphoma; Cancer research; Oncology; Biology; Medicine; Gene; Internal medicine; Immunology; Gene expression; Genetics; Antigen; Antibody","score_opus":0.018387532456470092,"score_gpt":0.25695840695917926,"score_spread":0.23857087450270917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106693055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824434,0.01300766,0.0000030811575,0.0017206117,0.00003536583,0.00037414633,0.00006772783,0.0000054386232,0.0023425734],"genre_scores_gemma":[0.9979388,0.0013383866,0.000036101974,0.00037308448,0.00011069216,0.00015481396,0.000021646263,0.000010159143,0.000016289743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991125,0.00003930551,0.0002649557,0.00017963337,0.0002876311,0.00011595791],"domain_scores_gemma":[0.9991129,0.000106077816,0.0004182855,0.00029033405,0.00003707398,0.00003529626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070750735,0.00010811007,0.00021093564,0.000023247785,0.000029268756,0.000012951199,0.00015076794,0.00004687921,0.000025455653],"category_scores_gemma":[0.000031432875,0.00005389646,0.00010594784,0.00015363643,0.000062423765,0.00008728787,0.000024608338,0.000046139146,0.0000030777715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004970547,0.003493067,0.26027596,0.00021807874,0.00015296481,0.000050038892,0.0043294774,0.0000588076,0.71242774,0.00016890575,0.0012173579,0.017110586],"study_design_scores_gemma":[0.0023366222,0.0001098313,0.45174372,0.00017476093,0.00014592374,0.0000033470517,0.0012360563,0.000021450953,0.54376704,0.000029642708,0.00039204856,0.000039526094],"about_ca_topic_score_codex":0.0003627048,"about_ca_topic_score_gemma":0.000026150796,"teacher_disagreement_score":0.19146778,"about_ca_system_score_codex":0.000039392497,"about_ca_system_score_gemma":0.00019174448,"threshold_uncertainty_score":0.21978338},"labels":[],"label_agreement":null},{"id":"W3107639073","doi":"10.1158/2643-3249.lymphoma20-po-62","title":"Abstract PO-62: Overcoming venetoclax resistance in B-cell malignancies by antagonism of stromal TGF-beta-mediated drug resistance","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Stromal cell; Cancer research; Tumor microenvironment; Stroma; Venetoclax; Drug resistance; Biology; Leukemia; Medicine; Immunology; Chemistry; Chronic lymphocytic leukemia; Tumor cells","score_opus":0.011651078915782424,"score_gpt":0.24598814918626805,"score_spread":0.23433707027048561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107639073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9431611,0.049305387,0.00009157681,0.003631234,0.00021472211,0.0006275087,0.0011996544,0.00009635348,0.0016725132],"genre_scores_gemma":[0.99378186,0.0013960039,0.0007637158,0.0012289538,0.00029475277,0.00013106177,0.00011687671,0.0001037713,0.0021829943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969253,0.00005966875,0.0008462814,0.00078276155,0.000694793,0.00069119054],"domain_scores_gemma":[0.99844396,0.00016535053,0.00051247055,0.0005260691,0.00011026178,0.00024190104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016837746,0.00046259598,0.0009495368,0.00010799146,0.000074625284,0.000046012254,0.00034288215,0.00014072002,0.00010709644],"category_scores_gemma":[0.000057444362,0.00046330263,0.00020631928,0.00057626626,0.00026005614,0.00064148154,0.00008921967,0.00047255756,0.00000875135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052558403,0.00047719516,0.028291244,0.0024976756,0.00032654303,0.0002900848,0.002483865,0.00019270818,0.95404017,0.00027671075,0.0055216323,0.00034632548],"study_design_scores_gemma":[0.014389559,0.0002027899,0.072704695,0.0025920959,0.00039738938,0.000007444251,0.0011101484,0.000015042603,0.8653067,0.00027182695,0.041969292,0.001033062],"about_ca_topic_score_codex":0.00041798424,"about_ca_topic_score_gemma":0.0008791464,"teacher_disagreement_score":0.088733524,"about_ca_system_score_codex":0.00041536105,"about_ca_system_score_gemma":0.0008555792,"threshold_uncertainty_score":0.99978185},"labels":[],"label_agreement":null},{"id":"W3108186512","doi":"10.1158/2643-3230.bcd-20-0155","title":"Sphingosine-1-Phosphate Receptor 3 Potentiates Inflammatory Programs in Normal and Leukemia Stem Cells to Promote Differentiation","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; National Institute of General Medical Sciences; Medical Research Council; Canadian Institutes of Health Research; Canadian Cancer Society; Wellcome Trust","keywords":"Haematopoiesis; Myeloid leukemia; Myelopoiesis; Myeloid; Stem cell; Biology; Immunology; Cancer research; Leukemia; Regulator; Hematopoietic stem cell; Cell biology; Inflammation; Genetics; Gene","score_opus":0.0126590363725166,"score_gpt":0.20717037093438026,"score_spread":0.19451133456186365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108186512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884794,0.008414636,0.00005944523,0.0007188753,0.001187124,0.0009542326,0.000052136398,0.000087492626,0.00004666174],"genre_scores_gemma":[0.9968764,0.0007429945,0.00007501193,0.0005547364,0.00012224425,0.00030470523,0.00006194737,0.000046179102,0.0012157534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834394,0.00009238495,0.00045152436,0.0005361408,0.0000763253,0.0004996513],"domain_scores_gemma":[0.9994644,0.000023361115,0.00017849456,0.00023123545,0.00004514716,0.00005735063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001311112,0.0002877284,0.0003659986,0.00007475408,0.00009871056,0.00009773033,0.0002503439,0.00021048721,0.00014483229],"category_scores_gemma":[0.000009576311,0.00027508408,0.0000736776,0.00024178362,0.000100198726,0.00044007358,0.00025030447,0.00034398874,0.00011743557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005458056,0.00011923409,0.047597922,0.00030594243,0.0002631989,0.000011699279,0.0028137881,0.00019853654,0.92278975,0.000044246182,0.0014139626,0.023895893],"study_design_scores_gemma":[0.0027602867,0.00029130816,0.014051227,0.00032573217,0.00011733197,0.000005841234,0.00028634458,0.000022454526,0.9665451,0.00001093415,0.015119983,0.0004634398],"about_ca_topic_score_codex":0.00033090007,"about_ca_topic_score_gemma":0.00013798744,"teacher_disagreement_score":0.04375535,"about_ca_system_score_codex":0.00015040256,"about_ca_system_score_gemma":0.00020018686,"threshold_uncertainty_score":0.99997014},"labels":[],"label_agreement":null},{"id":"W3108297018","doi":"10.1158/2643-3249.lymphoma20-po-22","title":"Abstract PO-22: Compromised counterselection by FAS creates a lethal subtype of germinal center lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Germinal center; Fas ligand; Biology; Apoptosis; Cancer research; B cell; Lymphoma; Programmed cell death; Immunology; Genetics; Antibody","score_opus":0.015872352401953147,"score_gpt":0.25832135466700124,"score_spread":0.2424490022650481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108297018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933746,0.0023027346,0.000008587774,0.0012465399,0.00014376965,0.00035145736,0.000395283,0.000042075517,0.002134996],"genre_scores_gemma":[0.997887,0.00049261434,0.000024929566,0.00085075543,0.00022868867,0.000085768,0.00015567544,0.000028565022,0.00024600312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877506,0.000017338743,0.0003008377,0.00034851683,0.00030570893,0.0002525483],"domain_scores_gemma":[0.99939984,0.0000398164,0.0001624093,0.00016865473,0.00007094971,0.00015833689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003449922,0.00021840382,0.0004135234,0.000037519672,0.00004547073,0.00004132948,0.00007625532,0.00008036987,0.0003027071],"category_scores_gemma":[0.000013502012,0.0001784005,0.00017740634,0.00014157363,0.00006926567,0.00019395124,0.000026726755,0.000059001006,0.000019707524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037002536,0.0061077415,0.820985,0.00076064444,0.0018039654,0.0003723824,0.00071759266,0.000012670892,0.12308059,0.000053850214,0.0322067,0.010198578],"study_design_scores_gemma":[0.020161211,0.0014964498,0.54332864,0.00046846026,0.0010688781,0.00010210855,0.00021481047,0.00005519597,0.4264431,0.000009080565,0.0063218665,0.0003302217],"about_ca_topic_score_codex":0.0015209676,"about_ca_topic_score_gemma":0.000035802168,"teacher_disagreement_score":0.3033625,"about_ca_system_score_codex":0.0001587781,"about_ca_system_score_gemma":0.0002772432,"threshold_uncertainty_score":0.72749615},"labels":[],"label_agreement":null},{"id":"W3108449195","doi":"10.1158/2643-3249.lymphoma20-po-32","title":"Abstract PO-32: NFKBIZ 3′ UTR mutations confer selective growth advantage and affect drug response in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Spinal Cord Injury BC; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Untranslated region; Biology; Mutation; Three prime untranslated region; Cancer research; Mutant; Cell growth; Signal transduction; CRISPR; Gene; Genetics; Lymphoma; Messenger RNA; Molecular biology; Immunology","score_opus":0.009652214431649287,"score_gpt":0.26292263908623864,"score_spread":0.2532704246545894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108449195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900686,0.0042986344,0.000007808821,0.0030945102,0.00007423168,0.00072750513,0.00047252484,0.000058634858,0.001197561],"genre_scores_gemma":[0.9960105,0.0013714018,0.000038401886,0.001729704,0.00012479007,0.00031941512,0.00007314401,0.00004506062,0.000287588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984334,0.0000997542,0.00027913708,0.0005359885,0.00025800525,0.0003937156],"domain_scores_gemma":[0.9990435,0.0003541892,0.0001044509,0.00019310955,0.00005498606,0.00024975382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013437567,0.00029346213,0.00045173086,0.000113031725,0.000087268905,0.000077674995,0.00007265424,0.00008130458,0.000046796904],"category_scores_gemma":[0.000101030564,0.00024724807,0.00012274137,0.0002892498,0.000064926564,0.00035050468,0.00006286354,0.00011538114,0.000023055825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014383042,0.031185875,0.9108918,0.0009236128,0.0010452316,0.0035894087,0.009776615,0.0000115472185,0.021410005,0.00054898637,0.0041714073,0.002062526],"study_design_scores_gemma":[0.051553655,0.00059737434,0.8627887,0.00024889843,0.00055347366,0.000031201296,0.00097556075,0.000033997883,0.08209245,0.000044876182,0.00076178997,0.00031803377],"about_ca_topic_score_codex":0.0006597475,"about_ca_topic_score_gemma":0.00034665113,"teacher_disagreement_score":0.060682442,"about_ca_system_score_codex":0.00024442023,"about_ca_system_score_gemma":0.0005143364,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W3109158687","doi":"10.1158/2643-3249.lymphoma20-po-04","title":"Abstract PO-04: Noncoding mutations in mantle cell lymphoma disrupt regulation of HNRNPH1 by alternative splicing","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Minigene; RNA splicing; Biology; Exonic splicing enhancer; Exon; Intron; Alternative splicing; Genetics; Exon skipping; Splicing factor; Silent mutation; Nonsense-mediated decay; Mutation; Cancer research; Molecular biology; RNA; Gene; Missense mutation","score_opus":0.01310041543215035,"score_gpt":0.27388398601723235,"score_spread":0.260783570585082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109158687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964938,0.0010551072,0.00077243446,0.0002601559,0.000040960607,0.00015711712,0.00013263198,0.0000048715965,0.0010829037],"genre_scores_gemma":[0.99865824,0.00033502546,0.00007725422,0.00012912229,0.00014885078,0.00002660711,0.00012932095,0.000018775056,0.00047680075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908096,0.00002523092,0.00022498898,0.00028468505,0.00017010981,0.00021400387],"domain_scores_gemma":[0.999619,0.000018058376,0.00011368112,0.0001387678,0.00003686464,0.000073624185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007221126,0.00011251665,0.00014209622,0.000037481812,0.00006377749,0.000026892088,0.00014062032,0.000059791888,0.000016380767],"category_scores_gemma":[0.000030617044,0.00011240249,0.00006425632,0.00013023838,0.000043870958,0.000026635658,0.000092753566,0.00006094923,0.0000024490218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088327404,0.00010398992,0.0091552725,0.0000755822,0.00003653339,0.000005229492,0.00021716004,0.0015239649,0.9870226,0.000015626269,0.00022630281,0.0015294189],"study_design_scores_gemma":[0.0013972553,0.00011756101,0.022684673,0.00006365844,0.000018687331,0.0000011793095,0.00025487083,0.0007119532,0.9743016,0.000029414687,0.00027803238,0.00014112078],"about_ca_topic_score_codex":0.0009465291,"about_ca_topic_score_gemma":0.00023394501,"teacher_disagreement_score":0.0135294,"about_ca_system_score_codex":0.000028436856,"about_ca_system_score_gemma":0.000114030794,"threshold_uncertainty_score":0.45836407},"labels":[],"label_agreement":null},{"id":"W3109625190","doi":"10.1158/2643-3249.lymphoma20-po-40","title":"Abstract PO-40: FOXO1 mutations mimic positive selection signals to promote germinal center B-cell expansion and lymphomagenesis","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Germinal center; FOXO1; B cell; Biology; Cancer research; Cancer; PI3K/AKT/mTOR pathway; Lymphoma; Transcription factor; Mutant; Gene; Genetics; Signal transduction; Immunology; Antibody","score_opus":0.010457849226037999,"score_gpt":0.24154343361516858,"score_spread":0.23108558438913057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109625190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959964,0.00055065134,0.0019353798,0.0006777935,0.0000837151,0.00035670405,0.00025936743,0.00002140109,0.000118598226],"genre_scores_gemma":[0.9981397,0.00011885411,0.00028078654,0.0007181828,0.00021413444,0.00005810513,0.0002413804,0.000029062292,0.00019983569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901116,0.000030620784,0.00018598732,0.00043540308,0.00014573803,0.00019110365],"domain_scores_gemma":[0.9996164,0.0000051067364,0.0000719367,0.000100633566,0.00007264115,0.0001333067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037080463,0.00017118492,0.00012513154,0.000041990417,0.000093743554,0.00007525017,0.00006996432,0.00009434084,0.000033344237],"category_scores_gemma":[0.000009454542,0.00017756691,0.00007554091,0.0001224937,0.000031648462,0.000037178095,0.000031304648,0.000049119622,0.000008687375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024356892,0.00012574464,0.0031436586,0.00005174475,0.000057367906,0.0000028477482,0.0002520173,0.0005461508,0.9930842,0.0000021339806,0.0004080451,0.00208254],"study_design_scores_gemma":[0.0010105022,0.00031773848,0.0883138,0.000036828893,0.000088116096,0.000010023211,0.000060854294,0.00006678155,0.9088537,0.000006947949,0.0010152817,0.00021940109],"about_ca_topic_score_codex":0.00010216481,"about_ca_topic_score_gemma":0.0000705952,"teacher_disagreement_score":0.08517015,"about_ca_system_score_codex":0.000027272363,"about_ca_system_score_gemma":0.00011150027,"threshold_uncertainty_score":0.72409683},"labels":[],"label_agreement":null},{"id":"W3109872911","doi":"10.1158/2643-3249.lymphoma20-po-10","title":"Abstract PO-10: Histone 1 deficiency drives lymphoma through disruption of 3D chromatin architecture","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromatin; Biology; Missense mutation; Genetics; Mutant; Gene; Histone; Molecular biology; Phenotype","score_opus":0.010331494108093156,"score_gpt":0.2566450905430812,"score_spread":0.24631359643498807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109872911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837416,0.011266722,0.0015261795,0.00051508786,0.00017552989,0.00016707025,0.000451363,0.000012523878,0.0021439532],"genre_scores_gemma":[0.99566007,0.0023366471,0.000535347,0.0006084962,0.0004957412,0.000034323406,0.00015705876,0.000030124187,0.00014220746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989363,0.000015142625,0.0002733305,0.0003899679,0.00015986664,0.00022541224],"domain_scores_gemma":[0.99940664,0.000018473047,0.000182837,0.00027532375,0.000045209916,0.00007153196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034420376,0.00018898629,0.00021272764,0.000018176088,0.000055232143,0.00003290547,0.00020948301,0.00010606669,0.0000896875],"category_scores_gemma":[0.000062205996,0.00018155354,0.00012486125,0.000103059836,0.00011794049,0.00001260267,0.00011703049,0.00005451723,0.000005992975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024781443,0.00029900353,0.0013485679,0.00024844595,0.00011646324,0.000008479617,0.0005653899,0.0026361002,0.98009354,0.00023713066,0.0030161387,0.011182947],"study_design_scores_gemma":[0.0028316553,0.0009166267,0.030028364,0.00012855504,0.00026045606,0.0000145373315,0.00023633451,0.00004338413,0.931039,0.00032662725,0.033476617,0.0006978555],"about_ca_topic_score_codex":0.00023713471,"about_ca_topic_score_gemma":0.00012262537,"teacher_disagreement_score":0.04905453,"about_ca_system_score_codex":0.000027781747,"about_ca_system_score_gemma":0.0002646295,"threshold_uncertainty_score":0.7403538},"labels":[],"label_agreement":null},{"id":"W3110051212","doi":"10.1158/2643-3249.lymphoma20-ia42","title":"Abstract IA42: Detecting and quantifying mutations associated with treatment resistance in aggressive lymphomas using ctDNA","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; Queen's University; McGill University; Simon Fraser University","funders":"","keywords":"Oncology; Exome sequencing; Exome; Medicine; Precision medicine; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Population; Digital polymerase chain reaction; Rituximab; Bioinformatics; Biology; Mutation; Pathology; Genetics; Gene","score_opus":0.03169157068812597,"score_gpt":0.2752715269306022,"score_spread":0.24357995624247622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110051212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041957,0.00878382,0.000098086544,0.00014455555,0.000046922665,0.00016523384,0.00016360992,0.000007580687,0.00017059509],"genre_scores_gemma":[0.9980532,0.0012704309,0.000227537,0.00017753453,0.0001322011,0.00003814355,0.000049986378,0.000026394126,0.000024560459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918187,0.000018046549,0.00016715078,0.0003473469,0.0000797837,0.00020577897],"domain_scores_gemma":[0.99955034,0.000043607615,0.00018995893,0.00011385803,0.000032904292,0.00006931532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035355504,0.00015424618,0.0001643603,0.000025718886,0.000092082264,0.00007661396,0.00005735563,0.000067849134,0.0000032276005],"category_scores_gemma":[0.000118868855,0.00014402786,0.000038810613,0.000120482146,0.0000507916,0.000013213258,0.000037564063,0.00004960741,2.1821475e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088955107,0.00040241462,0.29387408,0.00016398895,0.0008453893,0.0003027229,0.0019069025,0.0129743265,0.68408626,0.00012766544,0.00007635137,0.0043503307],"study_design_scores_gemma":[0.015355038,0.0013239613,0.28256905,0.0015525657,0.0008649171,0.000031626718,0.0018341362,0.0011790982,0.6915872,0.00020820822,0.0017696179,0.001724542],"about_ca_topic_score_codex":0.00052604126,"about_ca_topic_score_gemma":0.010049,"teacher_disagreement_score":0.014465487,"about_ca_system_score_codex":0.00008687477,"about_ca_system_score_gemma":0.00029807276,"threshold_uncertainty_score":0.58732855},"labels":[],"label_agreement":null},{"id":"W3110516422","doi":"10.1158/2643-3249.lymphoma20-po-42","title":"Abstract PO-42: TBL1XR1 mutations drive extranodal lymphomagenesis by inducing a protumorigenic memory B-cell fate","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto","funders":"","keywords":"Germinal center; BCL6; Biology; Transcription factor; Cancer research; Phenotype; Cell fate determination; Lymphoma; Reprogramming; B cell; Immune system; Cell; Gene; Immunology; Genetics; Antibody","score_opus":0.02507749552767352,"score_gpt":0.2904823327413624,"score_spread":0.2654048372136889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110516422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319,0.0045069195,0.00011591066,0.0023621656,0.00019975098,0.0014652708,0.0003025434,0.00012497471,0.0077324808],"genre_scores_gemma":[0.9847895,0.0008380734,0.00012698257,0.0012541156,0.00078807725,0.0005466266,0.00011847178,0.000122053374,0.011416132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972727,0.00006890841,0.00045949954,0.0007545928,0.00078180735,0.00066253147],"domain_scores_gemma":[0.99872726,0.000093058865,0.00015171376,0.00045480506,0.00012302816,0.00045014903],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017337079,0.00035436737,0.0005024279,0.00012186278,0.00017224016,0.00014803659,0.00027429892,0.00014184856,0.003855737],"category_scores_gemma":[0.00005003581,0.00033535532,0.0002917231,0.0005646144,0.00014571538,0.00044762445,0.00008935305,0.0004197669,0.00014878645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062443415,0.000567794,0.004152598,0.000491583,0.0004036749,0.00026057207,0.0019252253,0.00010150294,0.975775,0.0000042110473,0.0036744247,0.012018963],"study_design_scores_gemma":[0.008136281,0.00048186316,0.012659371,0.00021394703,0.00057742,0.00004868566,0.0012728889,0.00010871315,0.9706259,0.000026169066,0.0053029642,0.0005458255],"about_ca_topic_score_codex":0.0011906317,"about_ca_topic_score_gemma":0.000081175036,"teacher_disagreement_score":0.011473137,"about_ca_system_score_codex":0.0002583301,"about_ca_system_score_gemma":0.0012734112,"threshold_uncertainty_score":0.9999098},"labels":[],"label_agreement":null},{"id":"W3110575363","doi":"10.1158/2643-3249.lymphoma20-po-26","title":"Abstract PO-26: Prognostic significance of Fc gamma receptor IIB expression in the response of previously untreated diffuse large B-cell lymphomas to anti-CD20 monoclonal antibodies: Differing impact of rituximab and obinutuzumab","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Rituximab; International Prognostic Index; CHOP; CD20; Tissue microarray; Immunohistochemistry; Lymphoma; Medicine; Diffuse large B-cell lymphoma; Monoclonal antibody; Cancer research; Internal medicine; Oncology; Antibody; Immunology","score_opus":0.022319615988263056,"score_gpt":0.3019578942477443,"score_spread":0.27963827825948123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110575363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927668,0.004269769,0.000014433279,0.0005207814,0.00003592254,0.0012855548,0.0010118601,0.000020453572,0.00007441227],"genre_scores_gemma":[0.99738497,0.0019633295,0.00016922271,0.00011130742,0.00009792402,0.00008380163,0.00004055367,0.000045550016,0.0001033447],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99727845,0.00023271103,0.0007555187,0.0004999065,0.0006907112,0.0005426936],"domain_scores_gemma":[0.9982481,0.00066606456,0.00032227873,0.0003710103,0.00014642798,0.00024612455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004210075,0.0003502825,0.00096029154,0.0001764864,0.00006309519,0.00003115898,0.00032092095,0.00011515383,0.0000867476],"category_scores_gemma":[0.0003343961,0.00022600348,0.00026340716,0.00053446635,0.00021600518,0.00019827492,0.00019252187,0.0002696005,0.0000040231116],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017402582,0.0023286424,0.3101683,0.0017556143,0.0001697338,0.00007920618,0.003225973,0.0000722163,0.664195,0.0000058220544,0.00030133902,0.00029554273],"study_design_scores_gemma":[0.010299578,0.0023732611,0.64265895,0.0016434591,0.00014940894,0.0000142874915,0.00054328283,0.00011974264,0.34184745,0.000006167703,0.00011162055,0.00023276621],"about_ca_topic_score_codex":0.0015151127,"about_ca_topic_score_gemma":0.000055250755,"teacher_disagreement_score":0.33249068,"about_ca_system_score_codex":0.00011430398,"about_ca_system_score_gemma":0.00078564836,"threshold_uncertainty_score":0.9216155},"labels":[],"label_agreement":null},{"id":"W3200480347","doi":"10.1158/2643-3230.bcd-20-0208","title":"NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity","year":2021,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Parker Institute for Cancer Immunotherapy; Entertainment Industry Foundation; Cancer Research Institute; Burroughs Wellcome Fund; Stanford Maternal and Child Health Research Institute; American Association for Cancer Research","keywords":"Haematopoiesis; Progenitor cell; Proinflammatory cytokine; Cancer research; CD34; Endothelial stem cell; Stem cell; Bone marrow; Myeloid; Immunology; Biology; In vitro; Cell biology; Inflammation","score_opus":0.016251784645069246,"score_gpt":0.3011283694173624,"score_spread":0.2848765847722931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200480347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262184,0.00079679565,0.00020655792,0.00041675504,0.00044464017,0.0009068228,0.0006349438,0.000101585996,0.0038700472],"genre_scores_gemma":[0.96325064,0.00044091296,0.0004809038,0.00058540894,0.0007835646,0.00022153324,0.00009433526,0.0001215949,0.034021094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99700445,0.00023347301,0.00030028346,0.00084520155,0.0008964175,0.00072017434],"domain_scores_gemma":[0.99821895,0.0003293617,0.00012978411,0.0007128783,0.00033290315,0.00027610234],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029190205,0.00038748237,0.0007917842,0.000110876084,0.00013674947,0.00020401846,0.00017257116,0.00017505295,0.0023943933],"category_scores_gemma":[0.000091314374,0.0003145029,0.00028834838,0.00047405405,0.00028386252,0.000395641,0.00011913636,0.0005820015,0.000042479587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008557337,0.0008173629,0.022575436,0.00024469887,0.0009929335,0.00093926874,0.00028787163,0.00010597805,0.962678,0.000011502389,0.000405681,0.0023839392],"study_design_scores_gemma":[0.015430751,0.0005501407,0.018785374,0.00021183533,0.00039193293,0.00011651239,0.00006402778,0.00007699644,0.95239586,0.00001564677,0.01159977,0.00036117286],"about_ca_topic_score_codex":0.0015287383,"about_ca_topic_score_gemma":0.00035777985,"teacher_disagreement_score":0.030151049,"about_ca_system_score_codex":0.00029822087,"about_ca_system_score_gemma":0.0017075749,"threshold_uncertainty_score":0.9999307},"labels":[],"label_agreement":null},{"id":"W3206893004","doi":"10.1158/2643-3230.bcd-20-0216","title":"Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target","year":2021,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; Amgen (Canada); Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Novo Nordisk Fonden; Canadian Institutes of Health Research; KWF Kankerbestrijding; Novo Nordisk; Canadian Cancer Society; Hospital for Sick Children; Government of Ontario","keywords":"Profiling (computer programming); Translation (biology); Messenger RNA; Central nervous system; Neuroscience; Computational biology; Biology; Computer science; Gene; Genetics","score_opus":0.019965264870598607,"score_gpt":0.2902066750362585,"score_spread":0.2702414101656599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206893004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858183,0.009279807,0.0022653674,0.00029703355,0.0004878877,0.0005942591,0.00014466609,0.00007768248,0.0010349429],"genre_scores_gemma":[0.9966252,0.00042012814,0.0008888211,0.0001237805,0.00034906258,0.00009760217,0.0001293753,0.00005116619,0.0013148885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978563,0.00009914422,0.00047139262,0.0004256411,0.00066452165,0.00048297775],"domain_scores_gemma":[0.99900824,0.00011645671,0.0001462825,0.00039439916,0.00020118718,0.00013346314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015086847,0.00020871795,0.0004629238,0.00010924719,0.0000745079,0.000069903814,0.00013740292,0.00013703249,0.00008706458],"category_scores_gemma":[0.0000489401,0.00018431943,0.00020852535,0.00036427286,0.0001063656,0.0003142402,0.000048188107,0.0002218067,0.00001408515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010864089,0.00033779303,0.019429594,0.004132525,0.001491572,0.00064920366,0.0014458873,0.0021219307,0.96192753,0.0008820615,0.0002648605,0.0062306453],"study_design_scores_gemma":[0.0064070877,0.00015369098,0.010184012,0.0011696591,0.00088483485,0.00034083377,0.0018064752,0.009536072,0.9689328,0.00009940235,0.00023131187,0.00025383438],"about_ca_topic_score_codex":0.00109287,"about_ca_topic_score_gemma":0.00007495348,"teacher_disagreement_score":0.010806822,"about_ca_system_score_codex":0.0010731252,"about_ca_system_score_gemma":0.0043780482,"threshold_uncertainty_score":0.7766469},"labels":[],"label_agreement":null},{"id":"W4220858033","doi":"10.1158/2643-3230.bcd-21-0092","title":"Reconstructing Complex Cancer Evolutionary Histories from Multiple Bulk DNA Samples Using Pairtree","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Vector Institute; Artificial Intelligence in Medicine (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health","keywords":"clone (Java method); Cancer; Genome; Phylogenetics; Disease; Complex disease","score_opus":0.03286776492797187,"score_gpt":0.25265744275172075,"score_spread":0.2197896778237489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220858033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730848,0.017967904,0.00028211155,0.00020874337,0.0015969358,0.00018757126,0.006517626,0.000020841297,0.00013346376],"genre_scores_gemma":[0.9940218,0.001114625,0.0016475801,0.00055478513,0.0013508649,0.00022566583,0.0007937562,0.000052409272,0.00023855656],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853677,0.000060028477,0.00028847592,0.0005593129,0.00021523492,0.00034019814],"domain_scores_gemma":[0.9992037,0.0000696258,0.00020101036,0.0003846134,0.00006134331,0.000079754194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007209792,0.00022532373,0.00023685383,0.00004622645,0.0004997818,0.00005588144,0.00026758332,0.00006892408,0.0002837554],"category_scores_gemma":[0.00006281329,0.00026599612,0.00014560026,0.00011769391,0.00012063387,0.000016159542,0.00046600806,0.00014374926,7.1485005e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024322636,0.00013906338,0.3441224,0.000029305093,0.0003737426,0.0000103730445,0.0001754567,0.014309806,0.6297942,0.00010946589,0.008638487,0.0020544895],"study_design_scores_gemma":[0.0066426317,0.0005502581,0.07346857,0.0001350205,0.0010089726,0.00010276636,0.0031990749,0.005129599,0.15388829,0.0012558234,0.75199157,0.0026274207],"about_ca_topic_score_codex":0.015591623,"about_ca_topic_score_gemma":0.004363949,"teacher_disagreement_score":0.74335307,"about_ca_system_score_codex":0.00031628914,"about_ca_system_score_gemma":0.000710923,"threshold_uncertainty_score":0.9999792},"labels":[],"label_agreement":null},{"id":"W4220999992","doi":"10.1158/2643-3230.bcd-22-0013","title":"Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Hope Foundation; American Cancer Society","keywords":"Malignancy; Risk factor; Population; Cancer; Disease; Risk assessment","score_opus":0.03486765714881442,"score_gpt":0.33101593398611234,"score_spread":0.29614827683729794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220999992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861517,0.0020692984,0.00004831168,0.001998971,0.0003131598,0.001513939,0.0076787067,0.000072416464,0.00015347861],"genre_scores_gemma":[0.9888294,0.0010258846,0.00006395622,0.007526845,0.00015927326,0.0006200148,0.0005856612,0.0000496353,0.0011393589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979469,0.00015224148,0.00044857134,0.00043314253,0.00055823143,0.00046089152],"domain_scores_gemma":[0.99826586,0.0003497015,0.0003635614,0.0004336388,0.00017420469,0.0004130127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003247856,0.00023844925,0.0005415926,0.00018497267,0.00032512294,0.000021778034,0.00016162897,0.00007817092,0.0003979508],"category_scores_gemma":[0.00080474233,0.00021773909,0.00024203693,0.0004214931,0.00006839556,0.00017271304,0.00011426281,0.00017844871,0.0000014394662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004260347,0.001092497,0.9727114,0.0013686783,0.00039987284,0.000020435084,0.0007023879,0.00026604315,0.0013829923,0.000054498843,0.01508711,0.0026537317],"study_design_scores_gemma":[0.05236186,0.006867997,0.7207505,0.00051212125,0.0037717305,0.00008392794,0.0015534367,0.00012405147,0.01555998,0.00058052765,0.19680186,0.0010319896],"about_ca_topic_score_codex":0.023830703,"about_ca_topic_score_gemma":0.0012144666,"teacher_disagreement_score":0.25196087,"about_ca_system_score_codex":0.0009976375,"about_ca_system_score_gemma":0.0036962242,"threshold_uncertainty_score":0.9826697},"labels":[],"label_agreement":null},{"id":"W4248313354","doi":"10.1158/2643-3249.bcd-19-0039","title":"Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Institutes of Health; Cancer Research Society; National Natural Science Foundation of China; American Cyronics Society; U.S. Department of Defense","keywords":"Progenitor cell; Protein phosphatase 2; Cancer research; Biology; Immune system; Stem cell; Immunology; Leukemia; Apoptosis; Cell biology; Phosphatase; Phosphorylation","score_opus":0.015850457976143317,"score_gpt":0.20717159285903383,"score_spread":0.19132113488289051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248313354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957305,0.0026097863,0.000015745374,0.00009671699,0.0006117243,0.00028803144,0.0001138902,0.000020805868,0.00051275373],"genre_scores_gemma":[0.9978356,0.0005793255,0.000005408554,0.00028176422,0.000018110799,0.000029955592,0.00004599723,0.000016308764,0.0011875627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988434,0.00019475707,0.0003456216,0.0003433558,0.000052924996,0.00021995629],"domain_scores_gemma":[0.9993977,0.00012898253,0.00023078539,0.00014871992,0.00006445723,0.000029386645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008474252,0.00020123462,0.0003082204,0.00007961464,0.00017855412,0.0000320108,0.00008511357,0.00010280309,0.00006294644],"category_scores_gemma":[0.000017544819,0.00018544894,0.00006625958,0.00015435708,0.00010932752,0.0003797891,0.00008528562,0.00036840266,0.000010342705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015286491,0.0003322152,0.019493496,0.0001536856,0.0001238696,0.0000013628088,0.0031055342,0.000057940237,0.97359073,0.000010444668,0.0007017238,0.0009003195],"study_design_scores_gemma":[0.0038699028,0.0007996827,0.020065622,0.00021365577,0.000094606105,0.0000029596208,0.00771739,0.000034344223,0.96565473,0.0000021676174,0.0012910955,0.00025384498],"about_ca_topic_score_codex":0.0006271534,"about_ca_topic_score_gemma":0.0000978453,"teacher_disagreement_score":0.007936031,"about_ca_system_score_codex":0.0000678327,"about_ca_system_score_gemma":0.000091666865,"threshold_uncertainty_score":0.7562388},"labels":[],"label_agreement":null},{"id":"W4252017764","doi":"10.1158/2643-3249.bcd-19-0041","title":"Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institutes of Health; National Cancer Institute; KWF Kankerbestrijding; China Scholarship Council","keywords":"Somatic evolution in cancer; Biology; Somatic hypermutation; Genetics; Mutation; Leukemia; Deep sequencing; Cancer; Gene; Cancer research; Genome; B cell","score_opus":0.005172263114851585,"score_gpt":0.21391161211154608,"score_spread":0.2087393489966945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252017764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498963,0.003450913,0.00066014804,0.00014327496,0.00009784741,0.00009029294,0.00051465904,0.0000030662998,0.000050155868],"genre_scores_gemma":[0.99698955,0.0020952143,0.00005364902,0.0002498281,0.00042033705,0.000025256268,0.0001221916,0.000013129742,0.00003084184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932635,0.0000140176735,0.00018258247,0.0002465463,0.000100284655,0.00013022021],"domain_scores_gemma":[0.9997243,0.000021992462,0.000081817736,0.00008382044,0.000029669953,0.00005838794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031910287,0.00009990728,0.00012510711,0.00003405374,0.000018566541,0.000015921793,0.000072927076,0.000070945935,0.000011693196],"category_scores_gemma":[0.000035619887,0.000104373925,0.0000430774,0.00008673439,0.000021548287,0.0000062909235,0.00007333866,0.00004907346,7.559705e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037952338,0.00007299013,0.9281144,0.00013314403,0.000111313435,0.000016740336,0.00012140338,0.005429067,0.06453252,0.00031507693,0.000554824,0.00021901047],"study_design_scores_gemma":[0.006306299,0.0007241386,0.95924634,0.000049845698,0.00040303392,0.000022485709,0.00014479866,0.0011577047,0.03092696,0.00020159516,0.00037238735,0.00044443746],"about_ca_topic_score_codex":0.00014434995,"about_ca_topic_score_gemma":0.00017025787,"teacher_disagreement_score":0.033605564,"about_ca_system_score_codex":0.000030775904,"about_ca_system_score_gemma":0.00043123963,"threshold_uncertainty_score":0.4256245},"labels":[],"label_agreement":null},{"id":"W4281960949","doi":"10.1158/2643-3230.bcd-21-0205","title":"Perspectives on the Risk-Stratified Treatment of Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Multiple myeloma; Risk stratification; Stratification (seeds); Medicine; Oncology; Intensive care medicine; Internal medicine; Biology","score_opus":0.03138852994115597,"score_gpt":0.3023293460820964,"score_spread":0.2709408161409404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281960949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918018,0.0029945492,0.0000044336334,0.0011095159,0.00008198945,0.00087227824,0.0007386371,0.000023969811,0.002372856],"genre_scores_gemma":[0.9949984,0.0011012075,0.00004770668,0.000056946992,0.00013078128,0.0009922135,0.000036726833,0.000022051394,0.0026139994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998594,0.00015655848,0.00017208734,0.00031629077,0.0004979481,0.00026310777],"domain_scores_gemma":[0.9990251,0.00027497715,0.00011346103,0.00046093203,0.000041041287,0.00008446669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009336937,0.00016821898,0.0002648861,0.00007729669,0.0002916797,0.000021559421,0.0001092488,0.000018023034,0.000675603],"category_scores_gemma":[0.000065800275,0.00009874236,0.00020573265,0.0001951823,0.00010153959,0.00005985503,0.0000493024,0.00014696103,0.000008067416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00866562,0.014851547,0.8981817,0.00007856623,0.0055769407,0.00043266048,0.009771618,0.00087738363,0.022636663,0.003386903,0.0011932104,0.03434719],"study_design_scores_gemma":[0.036594283,0.014401285,0.7295085,0.000111743655,0.0015353775,0.00007160208,0.02753326,0.00084816717,0.18292594,0.00030553073,0.0057007954,0.00046347824],"about_ca_topic_score_codex":0.0027063314,"about_ca_topic_score_gemma":0.0002799091,"teacher_disagreement_score":0.16867316,"about_ca_system_score_codex":0.00029349016,"about_ca_system_score_gemma":0.0002926361,"threshold_uncertainty_score":0.73973787},"labels":[],"label_agreement":null},{"id":"W4294771021","doi":"10.1158/2643-3249.lymphoma22-a12","title":"Abstract A12: Pervasive hypermutation of super-enhancer regions dysregulates oncogene expression in diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Somatic hypermutation; Enhancer; Genetics; Gene; Cancer research; Germinal center; B cell; Gene expression","score_opus":0.012631251303586995,"score_gpt":0.2578647238791112,"score_spread":0.2452334725755242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294771021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842144,0.00911673,0.0000052879996,0.00048052624,0.00020744567,0.0005128223,0.00040980885,0.000026569402,0.0008193987],"genre_scores_gemma":[0.9960436,0.0017271889,0.00006085945,0.0002381717,0.00010133112,0.00080531766,0.00022057918,0.000038062317,0.00076487125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834853,0.000054039836,0.00039367686,0.00041951553,0.00045723066,0.00032699594],"domain_scores_gemma":[0.9992058,0.00009544473,0.00018444157,0.00036904792,0.0000529641,0.00009224888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009827584,0.00022131357,0.00041774477,0.00015797942,0.00013723322,0.000020938103,0.00011459978,0.00006575184,0.0003360909],"category_scores_gemma":[0.000015313139,0.00019075042,0.00019290097,0.00027804487,0.000044156943,0.00025295222,0.00012508473,0.000087732835,0.0000064518426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015463845,0.07944908,0.3312343,0.00068402727,0.00050881424,0.00087983254,0.0047146264,0.00056039635,0.569994,0.00031959254,0.0034516524,0.006657308],"study_design_scores_gemma":[0.036326908,0.000452517,0.33733973,0.0004192802,0.0004125886,0.00003980805,0.0019195745,0.00003547087,0.62082994,0.000102669546,0.00184632,0.00027520646],"about_ca_topic_score_codex":0.0008315486,"about_ca_topic_score_gemma":0.0002420039,"teacher_disagreement_score":0.07899657,"about_ca_system_score_codex":0.00047603468,"about_ca_system_score_gemma":0.0004654878,"threshold_uncertainty_score":0.7778576},"labels":[],"label_agreement":null},{"id":"W4294771401","doi":"10.1158/2643-3249.lymphoma22-a19","title":"Abstract A19: Integrated single cell analysis reveals co-evolution of malignant B cells and the tumor microenvironment in transformed follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Follicular lymphoma; Transcriptome; Lymphoma; Somatic evolution in cancer; Tumor microenvironment; Cancer research; Phenotype; Cancer; Genetics; Gene; Immunology; Tumor cells; Gene expression","score_opus":0.0067827158771484415,"score_gpt":0.21553513545212058,"score_spread":0.20875241957497215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294771401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881808,0.009864158,0.000018484381,0.00037664617,0.000052130432,0.0007321584,0.00048091996,0.000008262414,0.0002864156],"genre_scores_gemma":[0.9976767,0.0013283844,0.000031483483,0.00019317998,0.000017829427,0.00045672787,0.00008395711,0.000016883689,0.00019488337],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99853295,0.00009586278,0.00043984925,0.00033635562,0.00034859483,0.00024640502],"domain_scores_gemma":[0.99936587,0.000079702324,0.00019550069,0.00028076884,0.000013831391,0.00006434227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000254765,0.00019433266,0.0005639098,0.00017392832,0.00009134941,0.000022368986,0.00008992218,0.000031296397,0.00018115071],"category_scores_gemma":[0.0000039896477,0.00012787055,0.00028401674,0.0004537273,0.00012723786,0.00008263525,0.00003745358,0.00006844933,0.0000013149205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003242755,0.011345806,0.4286745,0.00047615866,0.004171807,0.00052199134,0.0018840289,0.0032415134,0.5423043,0.00015995152,0.0006267668,0.0033504535],"study_design_scores_gemma":[0.019302564,0.00044034014,0.56163615,0.00014171629,0.0047349995,0.000026386406,0.001758875,0.000102923186,0.4106449,0.00003957395,0.00095496216,0.00021659936],"about_ca_topic_score_codex":0.0049642427,"about_ca_topic_score_gemma":0.00029324394,"teacher_disagreement_score":0.13296168,"about_ca_system_score_codex":0.00078259176,"about_ca_system_score_gemma":0.00019125575,"threshold_uncertainty_score":0.7504483},"labels":[],"label_agreement":null},{"id":"W4294775244","doi":"10.1158/2643-3249.lymphoma22-a24","title":"Abstract A24: <i>BTG1</i> mutations confer a fitness advantage and promote aggressive B cell lymphoma development by lowering the threshold for MYC induction","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Germinal center; Lymphoma; Cancer research; Mutation; B cell; Immunology; Genetics; Gene; Antibody","score_opus":0.00733294582110307,"score_gpt":0.2367027978724541,"score_spread":0.22936985205135102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294775244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997396,0.00787431,0.0005172706,0.00022005894,0.00034746024,0.00062692526,0.0003045456,0.00001198158,0.0001235117],"genre_scores_gemma":[0.9968296,0.00036960904,0.000059136244,0.00011169278,0.00016793386,0.0009844914,0.0005313017,0.000033202086,0.00091299077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905,0.000015480904,0.0001965452,0.00036636138,0.00016305585,0.00020851384],"domain_scores_gemma":[0.9994955,0.000011182836,0.00021444258,0.00019466068,0.000045739245,0.000038454007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093482464,0.00015681941,0.000108727676,0.000027635238,0.00038866853,0.00006272696,0.000121490004,0.00006905299,0.000018109451],"category_scores_gemma":[0.0000070906485,0.00014149823,0.000055456294,0.0000816376,0.00006324773,0.000022377959,0.00012649522,0.00007628825,3.9416992e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002521521,0.00024659213,0.0005543957,0.00009588161,0.00021115274,0.0000028836814,0.00055437954,0.004430333,0.9769877,0.00001819105,0.0022187359,0.014427563],"study_design_scores_gemma":[0.002298773,0.00014868406,0.002007675,0.000038971204,0.00011348584,0.000028793373,0.00059148273,0.00008002676,0.95199424,0.000058853726,0.042330895,0.00030814568],"about_ca_topic_score_codex":0.00004857027,"about_ca_topic_score_gemma":0.00009438522,"teacher_disagreement_score":0.040112156,"about_ca_system_score_codex":0.00008495251,"about_ca_system_score_gemma":0.00031895345,"threshold_uncertainty_score":0.577013},"labels":[],"label_agreement":null},{"id":"W4294919189","doi":"10.1158/2643-3230.bcd-22-0120","title":"Q&amp;A: John Dick on Stem Cells and Discoveries","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Environmental ethics; Biology; Philosophy; Cell biology","score_opus":0.025851825218452206,"score_gpt":0.27918615735533814,"score_spread":0.25333433213688594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294919189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817096,0.0034858023,0.0000849183,0.011913162,0.00078008295,0.00028928224,0.00025919708,0.000040200535,0.001437767],"genre_scores_gemma":[0.9830031,0.0010678902,0.00002996683,0.0019507371,0.0002771267,0.000087622095,0.00003788946,0.00002296703,0.013522748],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879396,0.000043191427,0.00017031188,0.00028852382,0.00051347393,0.0001905471],"domain_scores_gemma":[0.9995377,0.000047191985,0.000070060996,0.0002182215,0.000017526994,0.00010931304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014360274,0.0001269185,0.00021185986,0.00006654119,0.00021846282,0.000045360874,0.00006173058,0.00006482929,0.00025464685],"category_scores_gemma":[0.0000033791205,0.00009711232,0.000067773166,0.0001691659,0.00030097857,0.00010971597,0.00013362896,0.00033515194,0.00000436609],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00804327,0.008354455,0.05814523,0.0047477623,0.0035879207,0.0006239567,0.014055426,0.0022595923,0.34953552,0.13945116,0.11869232,0.2925034],"study_design_scores_gemma":[0.0075515257,0.0021439523,0.04084911,0.0005212123,0.000950932,0.000123987,0.0017714475,0.00015835694,0.032636404,0.003043667,0.9094569,0.00079251773],"about_ca_topic_score_codex":0.00019533347,"about_ca_topic_score_gemma":0.000059328424,"teacher_disagreement_score":0.7907646,"about_ca_system_score_codex":0.000068929265,"about_ca_system_score_gemma":0.00020606146,"threshold_uncertainty_score":0.39601254},"labels":[],"label_agreement":null},{"id":"W4319827008","doi":"10.1158/2643-3230.bcd-22-0086","title":"<i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Stem cell; RNA-binding protein; In vivo; RNA; Cell biology; Computational biology; Biology; Genetics; Gene","score_opus":0.02521687011719345,"score_gpt":0.29304056083478136,"score_spread":0.26782369071758794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319827008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934937,0.0030482274,0.000027901608,0.0012505525,0.00014830616,0.0013757901,0.00009010523,0.00008646897,0.00047895376],"genre_scores_gemma":[0.970374,0.00212647,0.00010749442,0.00041214676,0.00017543041,0.00058669987,0.000011456297,0.00008131071,0.026124975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971128,0.000144573,0.00046633178,0.0006949364,0.0007106622,0.0008706969],"domain_scores_gemma":[0.9990905,0.0001986161,0.0001220556,0.00037294228,0.000061343024,0.00015456835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005880465,0.00032843163,0.00057785556,0.00064901833,0.00011766919,0.0001862252,0.00025673088,0.00017771705,0.000112195085],"category_scores_gemma":[0.00004529179,0.00030107616,0.00010946152,0.0011374224,0.00016700776,0.00087480055,0.0002719285,0.00067681295,0.00005448583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004099729,0.00008350779,0.026285373,0.0005688941,0.00021146127,0.0012673063,0.0019916124,0.00017699922,0.9671106,0.00010894495,0.00089529733,0.0008900653],"study_design_scores_gemma":[0.005264079,0.00023158862,0.004412975,0.0016314446,0.00012086157,0.00008125696,0.007233417,0.0005057006,0.9790651,0.00044500278,0.000569815,0.0004387314],"about_ca_topic_score_codex":0.0032678822,"about_ca_topic_score_gemma":0.00097551796,"teacher_disagreement_score":0.025646022,"about_ca_system_score_codex":0.000564692,"about_ca_system_score_gemma":0.0010804913,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W4367553368","doi":"10.1158/2643-3249.aml23-ia03","title":"Abstract IA03: Inducing apoptosis in leukemia stem cells by targeting metabolism","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Myeloid leukemia; Leukemia; Cancer research; Stem cell; Apoptosis; Medicine; Cancer; Population; Disease; Myelodysplastic syndromes; Cancer stem cell; Immunology; Biology; Bone marrow; Internal medicine; Cell biology; Genetics","score_opus":0.02077000338986654,"score_gpt":0.2875100773813973,"score_spread":0.2667400739915307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367553368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928454,0.003452315,0.00001004858,0.00093554537,0.00045015,0.0005481865,0.0001745336,0.0001774811,0.0014063034],"genre_scores_gemma":[0.98970205,0.0031950108,0.000084947686,0.0004940844,0.00059434836,0.00024975324,0.000096115924,0.00010609523,0.005477613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697524,0.00006888934,0.00055607245,0.0006938918,0.00073062925,0.00097527495],"domain_scores_gemma":[0.99889827,0.00018808678,0.00014399242,0.00046595803,0.00006993689,0.00023376406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068811653,0.00032119162,0.0006106759,0.0004049911,0.000106601045,0.00011920303,0.00029494608,0.00022505867,0.00016710057],"category_scores_gemma":[0.00005610302,0.00029353166,0.00016859503,0.0013222422,0.000080960555,0.0005627003,0.00022018552,0.00089251605,0.0001862525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018882609,0.00013745094,0.01068869,0.00047938683,0.00030841643,0.00016220068,0.0007481221,0.0005789584,0.8867497,0.00003084962,0.09211352,0.007813913],"study_design_scores_gemma":[0.0046497807,0.00006115784,0.022109633,0.0005627316,0.00023552927,0.00000687869,0.0016475664,0.00031441185,0.9562709,0.000029642151,0.013608137,0.00050366606],"about_ca_topic_score_codex":0.004366888,"about_ca_topic_score_gemma":0.00007941524,"teacher_disagreement_score":0.07850538,"about_ca_system_score_codex":0.00093026506,"about_ca_system_score_gemma":0.0013197348,"threshold_uncertainty_score":0.99995166},"labels":[],"label_agreement":null},{"id":"W4367603663","doi":"10.1158/2643-3249.aml23-a16","title":"Abstract A16: Multi-omic analyses in genetically engineered mice reveal distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; IDH2; Haematopoiesis; Isocitrate dehydrogenase; Epigenetics; Progenitor cell; Myeloid; DNA methylation; Myeloid leukemia; Stem cell; Cancer research; IDH1; Genetics; Mutation; Gene; Gene expression; Enzyme; Biochemistry","score_opus":0.026295459260253014,"score_gpt":0.3194442679006793,"score_spread":0.2931488086404263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367603663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990924,0.0077357455,0.000023751589,0.0002021538,0.00004392847,0.0009462688,0.00008713189,0.000025499208,0.000011529178],"genre_scores_gemma":[0.99773747,0.0014840055,0.0002599257,0.000029208702,0.000048944647,0.00017089816,0.000020925805,0.000037921713,0.00021072252],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99849486,0.00006394552,0.00040633432,0.00043021026,0.0002416688,0.00036297925],"domain_scores_gemma":[0.99914724,0.00036702247,0.00007745404,0.00020012265,0.000041800475,0.00016633526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018071814,0.00021315245,0.00049107434,0.00036714395,0.000034183027,0.000044236265,0.00008095122,0.00011018562,0.0000028430522],"category_scores_gemma":[0.00008092564,0.00019131263,0.000051541978,0.00053020305,0.00017178606,0.00013913059,0.00011759931,0.00025551586,0.0000019970803],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019097395,0.00016420094,0.09458684,0.0029513205,0.0001827923,0.00036397815,0.0007191414,0.00015640681,0.89880747,0.00000435928,0.000038921975,0.0018335689],"study_design_scores_gemma":[0.005528568,0.00014653549,0.74788624,0.00072427635,0.00033563253,0.000050982148,0.00024660648,0.0020510363,0.24281716,0.000014397957,0.000005975857,0.00019258738],"about_ca_topic_score_codex":0.0006751817,"about_ca_topic_score_gemma":0.00036406855,"teacher_disagreement_score":0.6559903,"about_ca_system_score_codex":0.00013884471,"about_ca_system_score_gemma":0.00036077757,"threshold_uncertainty_score":0.78015023},"labels":[],"label_agreement":null},{"id":"W4367603727","doi":"10.1158/2643-3249.aml23-a54","title":"Abstract A54: Polyamines are required for AML LSC function through their role in regulating eIF5A dependent protein synthesis","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Arginine; Haematopoiesis; Myeloid leukemia; Stem cell; Progenitor cell; Biology; Leukemia; Cancer research; Polyamine; Metabolite; Biochemistry; Myeloid; Cell biology; Immunology; Amino acid","score_opus":0.01811990868516516,"score_gpt":0.2624131206114914,"score_spread":0.24429321192632625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367603727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407357,0.003468005,0.00046453354,0.0003852192,0.0001321018,0.00062531757,0.0005237172,0.0000402521,0.00028729538],"genre_scores_gemma":[0.9948194,0.00036639808,0.000120277575,0.00008926792,0.0006233049,0.0023200687,0.00019688415,0.000040740153,0.0014236649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881756,0.000024021874,0.00026367244,0.00044803217,0.00011528412,0.00033144746],"domain_scores_gemma":[0.99936044,0.000029506898,0.00016068504,0.00037555548,0.000036719517,0.000037111495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013709177,0.00018812456,0.00019883973,0.000052709616,0.00010904091,0.00005319097,0.00017493905,0.00012347051,0.000008111712],"category_scores_gemma":[0.00007647478,0.00016947178,0.00011373649,0.00020455719,0.00003985424,0.00003223132,0.000085166685,0.000060383874,0.0000050113895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112502355,0.00010406393,0.0021349106,0.00007367789,0.00007471777,7.7221813e-7,0.000049438357,0.00018709531,0.9880185,0.00015752531,0.00045046903,0.008636324],"study_design_scores_gemma":[0.0007110036,0.000045927514,0.05507877,0.000116125164,0.00006969582,0.0000015515524,0.00062881113,0.000057793997,0.9353946,0.0009917113,0.0066249203,0.000279078],"about_ca_topic_score_codex":0.00035951848,"about_ca_topic_score_gemma":0.0006924477,"teacher_disagreement_score":0.05294386,"about_ca_system_score_codex":0.000015829542,"about_ca_system_score_gemma":0.000087985834,"threshold_uncertainty_score":0.6910859},"labels":[],"label_agreement":null},{"id":"W4387114589","doi":"10.1158/2643-3230.bcd-23-0062","title":"Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Institute of Cancer Research","funders":"National Cancer Institute","keywords":"Downregulation and upregulation; Cancer research; Enhancer; IRF4; In vivo; Transcription factor; Biology; Chemistry; Genetics; Gene","score_opus":0.044221167269561594,"score_gpt":0.33359791446182685,"score_spread":0.28937674719226525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387114589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953435,0.0012739813,0.00002505513,0.0014224319,0.00023881966,0.0006334041,0.00040541164,0.00013170076,0.0005256791],"genre_scores_gemma":[0.9952889,0.0007325292,0.0000983471,0.00013148379,0.00016226668,0.00059452286,0.00038021576,0.000040973613,0.0025707718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794585,0.000077143406,0.00032432715,0.00047547935,0.0005770605,0.00060012605],"domain_scores_gemma":[0.99921644,0.00017800977,0.00004575715,0.0003038592,0.00006595012,0.00019000322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019280509,0.00022742435,0.00034842006,0.0003024166,0.00016966203,0.00007474018,0.00012681237,0.000057822934,0.00015444779],"category_scores_gemma":[0.00009044002,0.00020157221,0.00019480257,0.0006783214,0.00009814616,0.0004907589,0.00006874639,0.00024031481,0.00008516451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031464064,0.0011885082,0.9527699,0.000186656,0.0003456812,0.00027966502,0.0004930739,0.000202785,0.03834287,0.00031745582,0.000387396,0.0051713674],"study_design_scores_gemma":[0.012910861,0.000090228925,0.95674783,0.00025801832,0.00010654683,0.000017429596,0.00025971726,0.0015224223,0.027124342,0.00015040029,0.0005887441,0.00022348104],"about_ca_topic_score_codex":0.0019511316,"about_ca_topic_score_gemma":0.005963243,"teacher_disagreement_score":0.01259622,"about_ca_system_score_codex":0.00021595827,"about_ca_system_score_gemma":0.00027149369,"threshold_uncertainty_score":0.8219876},"labels":[],"label_agreement":null},{"id":"W4387128075","doi":"10.1158/2643-3230.bcd-23-0049","title":"IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Narodowa Agencja Wymiany Akademickiej","keywords":"Hypogammaglobulinemia; Medicine; Antibody; Multiple myeloma; Internal medicine; Immunology; Confidence interval; Cumulative incidence; Incidence (geometry); Gastroenterology; Cohort","score_opus":0.0270653576593723,"score_gpt":0.27648295835949677,"score_spread":0.24941760070012448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387128075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805343,0.00010712042,0.0000025158515,0.00007416754,0.00007669328,0.0010219356,0.0003925502,0.00013798317,0.00013358743],"genre_scores_gemma":[0.9971852,0.00059441983,0.000031254796,0.0000091827405,0.00004577125,0.00022034544,0.0007192419,0.00005648801,0.0011381509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816424,0.00008040921,0.0003098487,0.0004398945,0.00051478285,0.00049081614],"domain_scores_gemma":[0.9990049,0.000116102136,0.00017415085,0.00032800942,0.000249987,0.00012687885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081102626,0.00026593395,0.0004957226,0.0005120155,0.00012286681,0.000058634592,0.000064871696,0.00008289293,0.000018231021],"category_scores_gemma":[0.00014432248,0.00018685107,0.00007799949,0.0016090343,0.00017144754,0.00055141834,0.000042166823,0.0001887869,0.000008547866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010895083,0.002096078,0.98762715,0.00008258561,0.0009415888,0.00018334671,0.00017475788,0.00033387612,0.006028975,0.0000039359606,0.00014740367,0.0012907721],"study_design_scores_gemma":[0.015193175,0.0013878638,0.96481305,0.000805215,0.000279046,0.000018682415,0.00013647086,0.00014432603,0.016993545,0.000002205523,0.000031903553,0.00019453364],"about_ca_topic_score_codex":0.005815551,"about_ca_topic_score_gemma":0.005707067,"teacher_disagreement_score":0.022814138,"about_ca_system_score_codex":0.00021509772,"about_ca_system_score_gemma":0.0002495296,"threshold_uncertainty_score":0.8791413},"labels":[],"label_agreement":null},{"id":"W4388451947","doi":"10.1158/2643-3230.bcd-23-0061","title":"ETV4-Dependent Transcriptional Plasticity Maintains <i>MYC</i> Expression and Results in IMiD Resistance in Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Paula and Rodger Riney Foundation; American Society of Hematology; Multiple Myeloma Research Foundation","keywords":"Transcription factor; Enhancer; Chromatin immunoprecipitation; Chromatin; Biology; Cancer research; Genetics; Promoter; Gene expression; Gene","score_opus":0.02987792591273875,"score_gpt":0.29229910765021666,"score_spread":0.2624211817374779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388451947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542445,0.0011411546,0.000025604395,0.0010289173,0.000096481715,0.0006484086,0.000808925,0.000057890495,0.00076818117],"genre_scores_gemma":[0.99589497,0.0014443152,0.0002347372,0.00010148699,0.00011021753,0.00033126323,0.00016672425,0.000028937506,0.0016873621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977257,0.0000949977,0.00045090538,0.00058829715,0.0005676212,0.00057245704],"domain_scores_gemma":[0.9992239,0.000253361,0.00006817845,0.0002226972,0.00003461154,0.00019723758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002759975,0.00021799299,0.00034212056,0.00031362384,0.000081850696,0.000047958485,0.00009797024,0.000090797745,0.00002497481],"category_scores_gemma":[0.00022834988,0.00018762721,0.00006507147,0.00044918284,0.000096784446,0.00029910723,0.000077385615,0.0003036951,0.000013967172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014917314,0.0012088189,0.74307615,0.00046007716,0.00013773027,0.0027192365,0.0011502692,0.0004416995,0.23303053,0.00028046453,0.0008277077,0.001749981],"study_design_scores_gemma":[0.026762951,0.00013753366,0.94753355,0.0009870176,0.00003942362,0.000013533197,0.00024943933,0.00040400785,0.022938397,0.00022859307,0.00050340965,0.00020212668],"about_ca_topic_score_codex":0.0014292797,"about_ca_topic_score_gemma":0.025466343,"teacher_disagreement_score":0.21009214,"about_ca_system_score_codex":0.00021979846,"about_ca_system_score_gemma":0.000248325,"threshold_uncertainty_score":0.99231637},"labels":[],"label_agreement":null},{"id":"W4392366857","doi":"10.1158/2643-3249.bcdsymp24-p11","title":"Abstract P11: ARID1A mutations shape memory B-cell dynamics and confer sensitivity to SWI/SNF remodeling complex inhibition in lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"ARID1A; SWI/SNF; Chromatin remodeling; Cancer research; Dynamics (music); Biology; Genetics; Cell biology; Mutation; Chemistry; Transcription factor; Gene; Physics","score_opus":0.013543540326741635,"score_gpt":0.2643173962480908,"score_spread":0.25077385592134915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392366857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264437,0.0025929743,0.0026391963,0.00032915053,0.00019731342,0.00020689628,0.00031702587,0.000032424483,0.001040669],"genre_scores_gemma":[0.9976444,0.0006533584,0.00030040188,0.0004399075,0.00024725526,0.00004277426,0.00036198192,0.00003778799,0.00027213467],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99878484,0.000032794393,0.00025355566,0.0005089233,0.00014223838,0.00027767205],"domain_scores_gemma":[0.9995913,0.000024617333,0.000041882657,0.00020025522,0.000051552637,0.000090429894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001640341,0.00019286577,0.00017468966,0.00008131067,0.00006974311,0.00014970316,0.000038861563,0.00012527357,0.000018828583],"category_scores_gemma":[0.000017321758,0.00020253877,0.000074639924,0.00013144567,0.000050471288,0.000026591855,0.00008262527,0.000094566465,0.000005311076],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083242085,0.00016184185,0.0005546877,0.00032284157,0.00006703913,0.000054191387,0.00027046207,0.035813726,0.93124974,0.000085903754,0.00043422272,0.030902112],"study_design_scores_gemma":[0.0035174147,0.0002198934,0.021892115,0.0011676276,0.00026239027,0.00014983302,0.0012442744,0.6484472,0.31978828,0.00042461924,0.0015424908,0.0013438652],"about_ca_topic_score_codex":0.0010444919,"about_ca_topic_score_gemma":0.0030602338,"teacher_disagreement_score":0.61263347,"about_ca_system_score_codex":0.00010593215,"about_ca_system_score_gemma":0.00030726663,"threshold_uncertainty_score":0.8259291},"labels":[],"label_agreement":null},{"id":"W4392384143","doi":"10.1158/2643-3249.bcdsymp24-p02","title":"Abstract P02: Uncovering Tailored Therapies for Acute Myeloid Leukemia in Children with Down Syndrome","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"","keywords":"Myeloid leukemia; Medicine; Down syndrome; Myeloid; Intensive care medicine; Immunology; Psychiatry","score_opus":0.011496967194867575,"score_gpt":0.2869133705003545,"score_spread":0.2754164033054869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392384143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875776,0.008498587,0.00018490403,0.0009926568,0.0001873525,0.0015308014,0.00035897057,0.00017350043,0.00049562345],"genre_scores_gemma":[0.99284136,0.0024211386,0.00040057543,0.000313707,0.0004043382,0.0008408255,0.00016369953,0.00013871807,0.0024756354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758995,0.000020486877,0.00036975316,0.00074344134,0.00052919704,0.0007471827],"domain_scores_gemma":[0.9991189,0.00011882203,0.000065423104,0.00047842992,0.000059884263,0.00015849301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024405759,0.00038433634,0.0005752861,0.00034857146,0.000083789404,0.00027380587,0.00026579853,0.00016656515,0.0001318179],"category_scores_gemma":[0.000020716667,0.00028348534,0.00018847534,0.00061803625,0.00014950367,0.0007895812,0.000093390045,0.00061641086,0.000027607824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011927556,0.0011105061,0.6025934,0.0058255293,0.04476643,0.008068013,0.005125084,0.0076068784,0.22449651,0.0018744528,0.019516379,0.067089215],"study_design_scores_gemma":[0.016010886,0.0019692588,0.9312769,0.004028447,0.0025264726,0.0025651052,0.0005288528,0.00068464957,0.033256754,0.000618326,0.005158395,0.0013759128],"about_ca_topic_score_codex":0.0021993718,"about_ca_topic_score_gemma":0.00041542374,"teacher_disagreement_score":0.3286835,"about_ca_system_score_codex":0.0015410273,"about_ca_system_score_gemma":0.0028278013,"threshold_uncertainty_score":0.99996173},"labels":[],"label_agreement":null},{"id":"W4392384615","doi":"10.1158/2643-3249.bcdsymp24-p19","title":"Abstract P19: Mitohormetic Regulation in Multiple Myeloma: Exploiting Mitochondrial Stress Responses for Therapeutic Gain","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"Multiple myeloma; Stress (linguistics); Medicine; Psychology; Internal medicine; Linguistics","score_opus":0.04870299445471482,"score_gpt":0.34121024415855455,"score_spread":0.29250724970383973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392384615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707867,0.008432628,0.0005618713,0.0010237033,0.00055506924,0.0015987589,0.00042770372,0.0001014745,0.000220127],"genre_scores_gemma":[0.99521935,0.00036402114,0.00058855326,0.000067526795,0.0009040306,0.0011203209,0.00018168129,0.00006436695,0.0014901594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981039,0.000067894216,0.0003719472,0.000528192,0.0004061357,0.00052188715],"domain_scores_gemma":[0.99866384,0.00079389167,0.000058328733,0.00029228968,0.000059543832,0.00013213043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017994676,0.00023976623,0.00032432165,0.00030988935,0.000095492665,0.00018355728,0.0000970423,0.000093793664,0.00007850964],"category_scores_gemma":[0.00021725993,0.000197659,0.00019151154,0.00028998667,0.00006605362,0.00043599517,0.000033206114,0.00021275245,0.000015045465],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015364932,0.0019738607,0.19382258,0.0033088168,0.0019283226,0.0010039345,0.0013536355,0.0007508323,0.6017194,0.0005142757,0.0012532166,0.17700619],"study_design_scores_gemma":[0.028598202,0.00092224375,0.62240577,0.004961993,0.000827041,0.000059418642,0.0008858352,0.011412797,0.3252295,0.0012233946,0.00273753,0.0007363004],"about_ca_topic_score_codex":0.00081227056,"about_ca_topic_score_gemma":0.0011407083,"teacher_disagreement_score":0.42858317,"about_ca_system_score_codex":0.00023463542,"about_ca_system_score_gemma":0.0004826684,"threshold_uncertainty_score":0.80603004},"labels":[],"label_agreement":null},{"id":"W4404970989","doi":"10.1158/2643-3230.bcd-23-0258","title":"CD33–CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Hyundai Hope On Wheels; Saban Research Institute; CureSearch for Children's Cancer; National Cancer Institute; St. Baldrick's Foundation; University of Southern California","keywords":"Interleukin-3 receptor; Cancer research; Haematopoiesis; CD33; Immunotherapy; Progenitor cell; Cytokine release syndrome; Leukemia; T cell; Stem cell; Immunology; Medicine; Biology; CD34; Myeloid; Chimeric antigen receptor; Cell biology; Immune system","score_opus":0.022163457041508895,"score_gpt":0.29113912565701067,"score_spread":0.26897566861550176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404970989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764208,0.015897054,0.0000624549,0.0007025814,0.00056905113,0.000578863,0.00007190405,0.00007433481,0.0056229183],"genre_scores_gemma":[0.99099046,0.0018396161,0.00016626346,0.00014157983,0.0013729107,0.000052305593,0.00001032461,0.00006683204,0.005359719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776655,0.0001277632,0.0004738519,0.00054291816,0.0006127203,0.00047616288],"domain_scores_gemma":[0.99877864,0.00047339933,0.000120077166,0.00040529645,0.00010426743,0.00011834815],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089360133,0.00025150957,0.00045762365,0.00010827277,0.00016877812,0.00017346264,0.00020401888,0.000099059056,0.0009253649],"category_scores_gemma":[0.00008964794,0.00017893373,0.00017517034,0.00041179007,0.00024709952,0.00027806696,0.00018558094,0.00052984495,0.000008391725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017121532,0.00009008976,0.0005537367,0.00067033607,0.00032358512,0.000029645405,0.003757163,0.00007695656,0.9818611,0.000058071248,0.0010518383,0.011356245],"study_design_scores_gemma":[0.00054699025,0.0001704023,0.0008025152,0.0008405838,0.0002746989,0.000014553392,0.003244321,0.00033144187,0.9917364,0.00011794631,0.0017193727,0.00020078401],"about_ca_topic_score_codex":0.0012383814,"about_ca_topic_score_gemma":0.00022245345,"teacher_disagreement_score":0.01456961,"about_ca_system_score_codex":0.00013356378,"about_ca_system_score_gemma":0.0004391604,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W4407345273","doi":"10.1158/2643-3230.bcd-24-0140","title":"SOCS1 Protects Acute Myeloid Leukemia against Allogeneic T Cell–Mediated Cytotoxicity","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Calgary; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Suppressor of cytokine signaling 1; Myeloid leukemia; Cancer research; CD8; Leukemia; Immunotherapy; Cytotoxic T cell; Immunology; Medicine; Biology; Cancer; Immune system; Internal medicine; In vitro; Suppressor","score_opus":0.011769062783451122,"score_gpt":0.2694262694282391,"score_spread":0.257657206644788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407345273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836145,0.0015269376,0.00045216037,0.0011852472,0.0005887178,0.0008802237,0.00027084642,0.00016897928,0.011312355],"genre_scores_gemma":[0.9868306,0.0012633458,0.00013465734,0.0032839237,0.00037976206,0.0004335122,0.00013898927,0.000038817234,0.007496383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984632,0.0000394031,0.00033111195,0.00048217163,0.0002702183,0.00041385993],"domain_scores_gemma":[0.99909174,0.00008105733,0.0001388193,0.0004416737,0.00011554823,0.00013113368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097407064,0.00027992827,0.00042045466,0.00019145478,0.00017471841,0.0000843159,0.00016268942,0.00015729268,0.00015374908],"category_scores_gemma":[0.000077766,0.00024406835,0.00025692675,0.0004641516,0.00007973381,0.00023922465,0.000097966855,0.00044510176,0.000041476473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023730188,0.0002960098,0.00269113,0.00021199233,0.0005887009,0.0000801303,0.000078722296,0.00015092311,0.9869745,0.000060089147,0.007663116,0.00096742995],"study_design_scores_gemma":[0.002684867,0.00020948051,0.004531342,0.0005733836,0.0006218176,0.0000152504845,0.000072277224,0.00018012273,0.9735071,0.000037744383,0.017304966,0.00026161625],"about_ca_topic_score_codex":0.0004008747,"about_ca_topic_score_gemma":0.00013852854,"teacher_disagreement_score":0.013467323,"about_ca_system_score_codex":0.00039605534,"about_ca_system_score_gemma":0.0016614922,"threshold_uncertainty_score":0.9952819},"labels":[],"label_agreement":null},{"id":"W4409872473","doi":"10.1158/2643-3230.bcd-24-0342","title":"Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs; Canada First Research Excellence Fund; Terry Fox Foundation; International Development Research Centre; National Cancer Institute; University of Toronto; Canadian Cancer Society; Government of Ontario; Princess Margaret Cancer Foundation; St. Jude Children's Research Hospital; American Lebanese Syrian Associated Charities; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Atlas (anatomy); Haematopoiesis; Biology; Hierarchy; Genetics; Computational biology; Evolutionary biology; Stem cell; Political science","score_opus":0.02081339611851763,"score_gpt":0.29090548888233614,"score_spread":0.2700920927638185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409872473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581957,0.0026769058,0.0003245041,0.00025167948,0.00006300219,0.0004319092,0.00013263948,0.000012074433,0.00028772076],"genre_scores_gemma":[0.99751407,0.00022007791,0.00039694353,0.000115779476,0.00004490485,0.0000663661,0.000031951502,0.00001999738,0.001589921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854916,0.00006556445,0.00048651753,0.00029271035,0.00037349653,0.00023252692],"domain_scores_gemma":[0.99926907,0.00009304825,0.00016069735,0.00028736982,0.00012098818,0.00006883287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111829155,0.00016252512,0.0004921213,0.0002510083,0.000056954403,0.00001802741,0.00011407025,0.00009574847,0.00006597596],"category_scores_gemma":[0.000026230455,0.0001434657,0.000127732,0.00024106108,0.00020342183,0.00009777752,0.000039225273,0.00013262409,5.135764e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002850948,0.0005423703,0.18595263,0.0025267527,0.00012544995,0.00001018122,0.0001711521,0.000009397354,0.8091353,0.00008101674,0.00025002615,0.0009106052],"study_design_scores_gemma":[0.0040653255,0.0003200916,0.36514536,0.0009149819,0.000473853,0.0000046268606,0.00004772086,0.00017667949,0.6284657,0.0002431918,0.000037371316,0.00010508188],"about_ca_topic_score_codex":0.00039807954,"about_ca_topic_score_gemma":0.00015917847,"teacher_disagreement_score":0.1806696,"about_ca_system_score_codex":0.00011196553,"about_ca_system_score_gemma":0.0004535766,"threshold_uncertainty_score":0.58503616},"labels":[],"label_agreement":null},{"id":"W4410192422","doi":"10.1158/2643-3230.bcd-24-0240","title":"DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"NHLBI Division of Intramural Research; National Cancer Institute; Canadian Institutes of Health Research; Pharmacyclics; EUSA Pharma; National Institute of Allergy and Infectious Diseases; MorphoSys; Terry Fox Research Institute; Michael Smith Health Research BC; Ministerio de Ciencia e Innovación; Canada's Michael Smith Genome Sciences Centre; Fundación Cellex; St. Jude Children's Research Hospital; Gilead Sciences; TG Therapeutics; Pfizer; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Amgen; Incyte; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"DNA methylation; Lymphoma; DNA; Burkitt's lymphoma; Methylation; Cancer research; Computational biology; Biology; Medicine; Genetics; Immunology; Gene; Gene expression","score_opus":0.009172808857633568,"score_gpt":0.3035139083737359,"score_spread":0.2943410995161023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410192422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98937225,0.0070915422,0.0000717751,0.001156842,0.000094537296,0.0002682077,0.00004132851,0.000016969052,0.0018865152],"genre_scores_gemma":[0.997862,0.00089036935,0.00017666243,0.0004283114,0.000051955896,0.000053173346,0.000023534058,0.0000100742145,0.0005039116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918723,0.00003786492,0.00022519326,0.0002665012,0.0001612029,0.00012197901],"domain_scores_gemma":[0.999459,0.00011570825,0.00009158246,0.00022401707,0.000053235202,0.000056441302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008235104,0.00013217403,0.00034871287,0.00005597655,0.000033013544,0.000023167691,0.00003956512,0.000069314934,0.000008455368],"category_scores_gemma":[0.000041637697,0.000088204,0.00009313864,0.00014673926,0.000116788804,0.00007856635,0.000037356032,0.00003803485,4.4872377e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070339866,0.0013004385,0.9233827,0.00023258712,0.0016629109,0.0000952035,0.000043396787,0.000005258886,0.0016205602,0.0024479176,0.0005180342,0.06798762],"study_design_scores_gemma":[0.0052156765,0.00041338467,0.8888389,0.00039434692,0.0017250264,0.000011481097,0.000028306868,0.0000042203715,0.10242764,0.0001821332,0.00067478925,0.00008408402],"about_ca_topic_score_codex":0.0005737898,"about_ca_topic_score_gemma":0.00022502386,"teacher_disagreement_score":0.10080708,"about_ca_system_score_codex":0.000048582668,"about_ca_system_score_gemma":0.00028346377,"threshold_uncertainty_score":0.35968545},"labels":[],"label_agreement":null},{"id":"W4410595562","doi":"10.1158/2643-3230.bcd-25-0099","title":"B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"H2020 Marie Skłodowska-Curie Actions; Fondazione Beretta; Fondazione Cariplo; American Society of Hematology; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"Gene silencing; B cell; Cancer research; Biology; Cell; Genetics; Gene; Antibody","score_opus":0.013868097935081475,"score_gpt":0.27053676845694474,"score_spread":0.25666867052186326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410595562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735877,0.018330267,0.000022075736,0.0011905009,0.00013884246,0.00079000514,0.000074149044,0.000026276726,0.005840183],"genre_scores_gemma":[0.9560406,0.011563654,0.00023294012,0.0007211455,0.000120391975,0.00012403452,0.0000104115725,0.0000358763,0.031150907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982505,0.00009296238,0.00030022804,0.00045287472,0.00053152454,0.00037192454],"domain_scores_gemma":[0.9989873,0.00019271935,0.00012964754,0.0004914496,0.00009626776,0.00010261614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003508456,0.00024147939,0.00045535405,0.00012026266,0.00013124813,0.00008307653,0.00017151976,0.000087982466,0.00016122877],"category_scores_gemma":[0.000020140773,0.00015742116,0.00006348325,0.00040165364,0.0003475352,0.00019879172,0.00014430226,0.00022849762,0.000001825785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000999358,0.00040511347,0.079197496,0.0011597667,0.00037494686,0.000020002724,0.0006228108,0.000007568217,0.9076926,0.00022886114,0.006892122,0.0023993424],"study_design_scores_gemma":[0.011913997,0.00063136267,0.007419755,0.0011237505,0.0008306054,0.000031362568,0.0015345013,0.0000084954,0.9633613,0.0002340227,0.012614931,0.00029588921],"about_ca_topic_score_codex":0.0022841904,"about_ca_topic_score_gemma":0.00028518846,"teacher_disagreement_score":0.071777746,"about_ca_system_score_codex":0.00009753291,"about_ca_system_score_gemma":0.00045795168,"threshold_uncertainty_score":0.6419449},"labels":[],"label_agreement":null},{"id":"W4410816810","doi":"10.1158/2643-3230.bcd-25-0049","title":"Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Heart, Lung, and Blood Institute; Division of Cancer Prevention, National Cancer Institute","keywords":"Lymphoblastic Leukemia; Genomics; Biology; Medicine; Leukemia; Genetics; Oncology; Gene; Genome","score_opus":0.014710577601451847,"score_gpt":0.31503978921649733,"score_spread":0.3003292116150455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410816810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958207,0.0012961506,0.00012990231,0.000137237,0.00020724408,0.0004132832,0.00017284449,0.000019404597,0.0018032609],"genre_scores_gemma":[0.9955251,0.0019148196,0.0001642834,0.00017841249,0.000073128365,0.000059096234,0.0000115418125,0.00003473469,0.0020388807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818707,0.000051017956,0.00044886526,0.00046852778,0.0003701054,0.0004744089],"domain_scores_gemma":[0.9989066,0.00032299958,0.000116048475,0.00045745773,0.000061817635,0.00013509014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115130555,0.00029037302,0.00072050246,0.0003224116,0.00003647115,0.00003886589,0.00019424333,0.00015404445,0.000028988916],"category_scores_gemma":[0.000076436954,0.00022740541,0.00016982589,0.0004206061,0.00019049407,0.00011994574,0.00015544641,0.00024130841,0.000004656663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012504187,0.00047754307,0.97045994,0.00039718678,0.00082004257,0.00018592978,0.00010609379,0.001642778,0.022772321,0.000061217324,0.00041321784,0.0014133255],"study_design_scores_gemma":[0.01178807,0.0007194403,0.97643733,0.0004091666,0.0005209805,0.000021749838,0.00006466527,0.0010668843,0.008626717,0.00010189769,0.00003109252,0.00021199779],"about_ca_topic_score_codex":0.0022005963,"about_ca_topic_score_gemma":0.00015727663,"teacher_disagreement_score":0.014145604,"about_ca_system_score_codex":0.002262967,"about_ca_system_score_gemma":0.0054728896,"threshold_uncertainty_score":0.97086716},"labels":[],"label_agreement":null},{"id":"W4412119851","doi":"10.1158/2643-3230.bcd-24-0327","title":"An Isoform-Specific RUNX1C–BTG2 Axis Governs AML Quiescence and Chemoresistance","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; Leukemia Research Foundation; National Cancer Institute; National Heart, Lung, and Blood Institute; Foundation for the National Institutes of Health; Butler Family Foundation","keywords":"Gene isoform; Cancer research; Biology; Myeloid leukemia; RNA; Transcription factor; Transcription (linguistics); Messenger RNA; Promoter; Chemotherapy; Molecular biology; Gene expression; Gene; Genetics","score_opus":0.00470263058249781,"score_gpt":0.2435911064997337,"score_spread":0.2388884759172359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412119851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97304606,0.022794625,0.0016873393,0.00039418394,0.0004320938,0.0002321505,0.00013963653,0.000026510896,0.0012473993],"genre_scores_gemma":[0.9870054,0.007741713,0.00017809725,0.0002648001,0.00040444257,0.00007844567,0.00010191361,0.000026422314,0.004198724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986764,0.000028337578,0.0002263017,0.00060418365,0.00016466447,0.00030006905],"domain_scores_gemma":[0.99919885,0.000008631793,0.00010027875,0.0005558365,0.00006264848,0.00007374033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008416211,0.00021781851,0.00018605776,0.000046159817,0.00012451156,0.000109674635,0.00021490682,0.0001750253,0.000020747111],"category_scores_gemma":[0.000012894679,0.0002267307,0.00007472682,0.00019779883,0.00014642002,0.000038419184,0.00009996531,0.000100790916,0.0000020428347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003743553,0.00014782562,0.01481292,0.00011315441,0.00018298744,0.0000025297757,0.000069803835,0.0004950666,0.961007,0.0008491644,0.0073933844,0.014551789],"study_design_scores_gemma":[0.0018198243,0.00023254941,0.105067424,0.00019405824,0.00013801562,0.000009294941,0.0001574005,0.00012892418,0.81345725,0.00028614685,0.077953905,0.0005551866],"about_ca_topic_score_codex":0.00014133475,"about_ca_topic_score_gemma":0.00093604036,"teacher_disagreement_score":0.14754975,"about_ca_system_score_codex":0.00007229993,"about_ca_system_score_gemma":0.00022364614,"threshold_uncertainty_score":0.924581},"labels":[],"label_agreement":null},{"id":"W4413976388","doi":"10.1158/2643-3230.bcd-25-0005","title":"Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell–Redirecting Immunotherapies","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Calgary","funders":"National Cancer Institute; National Institutes of Health","keywords":"Chimeric antigen receptor; CAR T-cell therapy; Multiple myeloma; Antigen; Immunology; Immunotherapy; Digital polymerase chain reaction; Medicine; Biology; Oncology; Cancer research; Genetics; Immune system; Polymerase chain reaction; Gene","score_opus":0.019038993411813976,"score_gpt":0.2854513872654947,"score_spread":0.2664123938536807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413976388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889231,0.0074153,0.000044570188,0.00020070633,0.00006561691,0.0006709806,0.000045009983,0.00006606491,0.0025686645],"genre_scores_gemma":[0.9942748,0.0011583167,0.00039220988,0.000118425254,0.000077419194,0.00021478413,0.000041505227,0.000039468203,0.0036830585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853903,0.000051107887,0.00025768214,0.0004224199,0.00022726732,0.0005024867],"domain_scores_gemma":[0.999352,0.000114200484,0.00007089815,0.00033066695,0.000052010553,0.00008024081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009892373,0.00024389327,0.00039470583,0.0002792755,0.0001312255,0.000070622555,0.00011552069,0.000062200146,0.000056272933],"category_scores_gemma":[0.000024803974,0.00018713118,0.00008491758,0.00045710686,0.00009197955,0.00020686624,0.00005900498,0.00020332784,0.000009535683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015093657,0.0004621715,0.9082658,0.00014996373,0.00058609794,0.00038880613,0.00027912244,0.00010582508,0.07695552,0.00000713824,0.00002911801,0.011261063],"study_design_scores_gemma":[0.016746506,0.00021891027,0.77884024,0.0008062438,0.00016921337,0.000020888543,0.00030815924,0.00035310627,0.20194583,0.000010075408,0.00036947225,0.00021135136],"about_ca_topic_score_codex":0.00738468,"about_ca_topic_score_gemma":0.0020054183,"teacher_disagreement_score":0.12942557,"about_ca_system_score_codex":0.00024186025,"about_ca_system_score_gemma":0.00044553346,"threshold_uncertainty_score":0.99922526},"labels":[],"label_agreement":null},{"id":"W4414228279","doi":"10.1158/2643-3230.bcd-25-0280","title":"Perspectives on Newly Diagnosed Myeloma Treatment and Emerging Challenges","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Multiple myeloma; Immunotherapy; MEDLINE; Clinical Practice; Daratumumab; Cancer","score_opus":0.026186199949584318,"score_gpt":0.329213792396261,"score_spread":0.30302759244667665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414228279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9190212,0.0630238,0.000007912458,0.0056796586,0.00009310431,0.00053730165,0.000040468145,0.000050254668,0.011546313],"genre_scores_gemma":[0.9429249,0.051886786,0.00007547711,0.00014109597,0.00015934267,0.00034344257,0.000010426117,0.000017174816,0.004441311],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988917,0.000039093527,0.00012458896,0.00045250435,0.00018296047,0.00030914287],"domain_scores_gemma":[0.99938303,0.00012168279,0.0000309333,0.0002977811,0.000038047743,0.00012850182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004377633,0.00020814699,0.0002971054,0.00016866617,0.00010971781,0.000047575304,0.000048782196,0.000042616757,0.000046376077],"category_scores_gemma":[0.000047927053,0.00015121308,0.00009246697,0.00012406944,0.00007451271,0.000121718054,0.00003947225,0.00008943005,0.000007494595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027494214,0.0049503255,0.16527644,0.00043288758,0.0049907975,0.001005787,0.006149672,0.000027453703,0.004308423,0.012278095,0.0005826379,0.79724807],"study_design_scores_gemma":[0.045549396,0.0037980506,0.89730704,0.0015090217,0.0013295116,0.00003221584,0.012684153,0.00011524782,0.02772329,0.000532066,0.008932874,0.00048713817],"about_ca_topic_score_codex":0.00089560536,"about_ca_topic_score_gemma":0.00051056995,"teacher_disagreement_score":0.7967609,"about_ca_system_score_codex":0.00021982632,"about_ca_system_score_gemma":0.0002193314,"threshold_uncertainty_score":0.61662906},"labels":[],"label_agreement":null},{"id":"W4415596352","doi":"10.1158/2643-3230.bcd-25-0130","title":"CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Conquer Cancer Foundation; Marcus Foundation; Tanoto Foundation; Johns Hopkins University; Paula and Rodger Riney Foundation; Multiple Myeloma Research Foundation; American Society of Clinical Oncology; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Leukemia and Lymphoma Society; National Institutes of Health","keywords":"Multiple myeloma; Downregulation and upregulation; Cytotoxicity; Cell culture; Tumor cells","score_opus":0.012603208836699872,"score_gpt":0.27011183621648716,"score_spread":0.2575086273797873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415596352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941562,0.002915794,0.00046358933,0.00021693626,0.0003868405,0.00089275534,0.00035250228,0.00004805755,0.00056734536],"genre_scores_gemma":[0.9958402,0.001528184,0.0005608578,0.00007502122,0.00019404369,0.0001880496,0.00010578654,0.00003187784,0.0014759611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979973,0.000117176096,0.00037790163,0.0005883963,0.00038570602,0.0005335539],"domain_scores_gemma":[0.99907386,0.00022698387,0.00010866429,0.0003507129,0.00007860079,0.00016118895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002560073,0.00027581782,0.00048211668,0.00023761987,0.00012416119,0.000090823574,0.00009793295,0.0001170275,0.000023227567],"category_scores_gemma":[0.00009330242,0.00023808166,0.00009918234,0.0003278208,0.000083123734,0.00051279913,0.00014235075,0.0002894152,0.000004520316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001556893,0.00065637013,0.8487105,0.0005581473,0.00070635305,0.0001409604,0.0003096135,0.0038895663,0.11754551,0.0005312779,0.00013524728,0.025259584],"study_design_scores_gemma":[0.028320067,0.00031374136,0.84834343,0.0006103837,0.0005222128,0.0000032263886,0.00030669285,0.03943871,0.08001441,0.0015182376,0.0001651749,0.00044372943],"about_ca_topic_score_codex":0.019009478,"about_ca_topic_score_gemma":0.0029857552,"teacher_disagreement_score":0.037531096,"about_ca_system_score_codex":0.00023685984,"about_ca_system_score_gemma":0.00030266654,"threshold_uncertainty_score":0.987523},"labels":[],"label_agreement":null},{"id":"W4416198715","doi":"10.1158/2643-3230.bcd-25-0408","title":"The Global State of Blood Cancers: An Ongoing Challenge","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"State (computer science); Cancer; Field (mathematics); Toll; Cancer treatment","score_opus":0.03640625996574852,"score_gpt":0.345158677566221,"score_spread":0.30875241760047245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416198715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432356,0.04079447,0.00013127994,0.0018398755,0.00051995594,0.0003770589,0.00014956888,0.00005531491,0.012896894],"genre_scores_gemma":[0.99103546,0.00658528,0.000099056066,0.0008265486,0.00022104457,0.000087810055,0.000008253748,0.000013738487,0.0011228157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982847,0.000048043163,0.0003964718,0.0003788842,0.00044375946,0.0004481186],"domain_scores_gemma":[0.9989466,0.00005722869,0.00015938566,0.00055920955,0.00015895219,0.00011859963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024373466,0.00020577924,0.00036682113,0.000044869175,0.0001839883,0.00008260581,0.00030019242,0.00006332147,0.000019075067],"category_scores_gemma":[0.000053871576,0.00015032869,0.00014956661,0.00045368905,0.00017579301,0.000391472,0.000104973435,0.00018604848,0.0000018073739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004585519,0.0014934327,0.6201393,0.0015853696,0.0062418827,0.00037725375,0.0020369387,0.0021148801,0.007222752,0.02604737,0.004819998,0.32333532],"study_design_scores_gemma":[0.03883526,0.009359932,0.63527346,0.01811215,0.017770939,0.00029378294,0.012852693,0.0015288738,0.13107572,0.034322537,0.09742186,0.0031528044],"about_ca_topic_score_codex":0.00749364,"about_ca_topic_score_gemma":0.013049601,"teacher_disagreement_score":0.32018253,"about_ca_system_score_codex":0.00024116311,"about_ca_system_score_gemma":0.0014852587,"threshold_uncertainty_score":0.9991155},"labels":[],"label_agreement":null},{"id":"W4417055360","doi":"10.1158/2643-3230.bcd-25-0246","title":"Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"HCA International Foundation; Wellcome Trust; Nationales Centrum für Tumorerkrankungen Heidelberg; Wilhelm Sander-Stiftung; José Carreras Leukämie-Stiftung; Joachim Herz Stiftung; Deutsche Forschungsgemeinschaft; Deutsches Krebsforschungszentrum","keywords":"Juvenile myelomonocytic leukemia; Reprogramming; Fetus; Mutation; Gene; PTPN11; Leukemia","score_opus":0.016722719833164538,"score_gpt":0.30993910152471,"score_spread":0.29321638169154546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417055360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899765,0.005198139,0.000100004625,0.0013250739,0.0000960699,0.0006866052,0.000031102314,0.000042377837,0.0025441085],"genre_scores_gemma":[0.99700385,0.00043577864,0.00022713347,0.0004914486,0.000061834515,0.0002773832,0.000013969799,0.000027243446,0.0014613478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977948,0.000135321,0.0005449528,0.0006723005,0.00030345016,0.00054915814],"domain_scores_gemma":[0.9990546,0.00034565467,0.00006955052,0.0003912098,0.00004833008,0.00009063293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047066167,0.00023801047,0.0005244915,0.00039773795,0.00005332624,0.00007895102,0.00014845651,0.00015920927,0.000009615036],"category_scores_gemma":[0.0003855674,0.00021835962,0.00007809696,0.0007114952,0.00023541485,0.0001810056,0.00017349834,0.0006812283,0.0000021893088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017923785,0.0022318156,0.5974953,0.005147379,0.0016482145,0.0047904444,0.0081747575,0.010568929,0.10810075,0.010685323,0.00089511165,0.23233816],"study_design_scores_gemma":[0.075017765,0.002093371,0.6703342,0.007547948,0.0012183436,0.0002011131,0.0075532803,0.019407805,0.20005406,0.007713479,0.0070281182,0.0018305043],"about_ca_topic_score_codex":0.005196757,"about_ca_topic_score_gemma":0.002371463,"teacher_disagreement_score":0.23050766,"about_ca_system_score_codex":0.0015603384,"about_ca_system_score_gemma":0.002143937,"threshold_uncertainty_score":0.8904447},"labels":[],"label_agreement":null}]}